Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 325–325 | Cite as

Raltegravir

Various toxicities: 2 case reports
Case report

Reference

  1. Calza L, et al. Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients. Journal of Antimicrobial Chemotherapy 74: 731-738, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1093/jac/dky507 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations